Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

8. BIOLOGICAL ASSETS: Schedule of Biological Assets (Details)

v3.21.2
8. BIOLOGICAL ASSETS: Schedule of Biological Assets (Details) - CAD ($)
Dec. 31, 2020
Dec. 31, 2019
Biological Assets, Carrying value $ 0 $ 0
Acquired from MAG acquisition    
Biological Assets, Carrying value 26,842 0
Capitalized cost    
Biological Assets, Carrying value 12,606,343 0
Fair value adjustment    
Biological Assets, Carrying value (543,116) 0
Transferred to inventory    
Biological Assets, Carrying value $ (12,090,069) $ 0